IMUN — Stock activity · TradeandTell
IMUN IMUN $0.09 -$0.01 (-7.00%) prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
Price Valuation Financials Segments
Held by traders on TradeandTell No one on the platform currently holds IMUN.
Super investors & insiders Institutions holding (13F)
No tracked institution reports a position in IMUN as of their last filing.
Insider activity (SEC Form 4)
Stock splits Execution date Ratio 2021-05-06 1-for-1000reverse
Recent trades on TradeandTell No one on the platform has traded IMUN yet.
Report a bug Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Peer comparison Symbol Price Today Mkt cap P/E IMUN Immune Therapeutics, Inc. $0.09 -7.00% $8M — BNOEF Bionomics Limited $0.01 -14.89% $9M — CRBKF Carebook Technologies Inc. $0.03 +0.00% $7M — FWPAY Forward Pharma A/S $300.00 -25.09% $7M — HBCNF HealthBeacon plc $0.50 +2269.67% $8M — IPCIF Intellipharmaceutics International Inc. $0.15 — $5M — MXDHF MDxHealth S.A. $0.25 -9.09% $9M —
Source: Financial Modeling Prep · peers by sector/industry
$IMUN chatter on StockTwits AHA @Stock_AHA Bullish Mar 12 $IMUX
If we reach a solution to the political problems (spically with canada) before April, we might see $IMUN above 10
View on StockTwits ↗ Immune Therapeutics, Inc. Files SEC Form 8-K $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗ Immune Therapeutics, Inc. Files SEC Form 10-Q $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗ Immune Therapeutics Sees Short Interest Increase from 100 shares to 300 shares. $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/short-
View on StockTwits ↗ $IMUN $IMUND Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky
https://www.stocktitan.net/news/IMUN/biostax-corp-announces-the-passing-of-esteemed-director-h-louis-62ryb6oi0hfn.html
View on StockTwits ↗ $IMUN $IMUND Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV
https://www.stocktitan.net/news/IMUN/biostax-corp-signs-collaboration-agreement-with-immgenuity-inc-to-cgg5uk7owzw1.html
View on StockTwits ↗ Immune Therapeutics, Inc. Files SEC Form 10-Q $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/sec-filings/
View on StockTwits ↗ $IMUN $IMUND Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH
https://www.stocktitan.net/news/IMUN/biostax-corp-announces-the-fd-as-acceptance-of-three-investigational-cqfee1gpr89n.html
View on StockTwits ↗ Immune Therapeutics Sees Short Interest Decrease from 200 shares to 100 shares. $IMUN https://www.marketbeat.com/stocks/OTCMKTS/IMUN/short-
View on StockTwits ↗ $IMUN [15s. delayed]: Issued Press Release on May 30, 09:00:00: Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare https://s.flashalert.me/eQ4mHi
View on StockTwits ↗ $IMUN Biostax Launches Growth Funding Round to Revitalize Affordable Healthcare
https://www.stocktitan.net/news/IMUN/biostax-launches-growth-funding-round-to-revitalize-affordable-osrdygdxhshp.html
View on StockTwits ↗ $IMUN [15s. delayed] filed form 10-Q on May 12, 15:57:40 https://s.flashalert.me/6TDBC
View on StockTwits ↗ Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
